Back
ESC Premium Access

Acute myocarditis with suppressed cardiac function is associated with a high risk of sudden cardiac death in the early phase that can be prevented by the wearable cardioverter defibrillator

Session: Poster Session 1 - Device treatment of ventricular arrhythmias and sudden cardiac death
Topic: Device Treatment
Speaker: Mrs A. Marx (Mainz, DE)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Mrs Alexandra Marx

Mainz (Germany)
0 follower

8 more presentations in this session

Prediction of ventricular tachyarrhythmias occurrence by changes in physiological parameters derived from implantable-cardioverter defibrillators

Speaker: Doctor N. Chan (Hong Kong, HK)

Access
Abstract
Slides
Thumbnail

An evaluation of the effect of the subcutaneous implantable defibrillator smartpass filter on inappropriate shock reduction.

Speaker: Doctor T. Brouwer (Amsterdam, NL)

Access
Abstract
Thumbnail

Modified ADMIRE-HF risk score predicts serious arrhythmic events in patients with implantable cardioverter defibrillator, regardless of left ventricular ejection fraction

Speaker: Doctor M. Kawasaki (Osaka, JP)

Access
Abstract
Slides
Thumbnail

The effectiveness of the wearable cardioverter defibrillator in a real world environment

Speaker: Doctor C. Abrahim (Springfield, US)

Access
Abstract
Slides
Thumbnail

Sudden cardiac arrest in patients with cardiac implantable electronic devices

Speaker: Doctor A. Sharifzadehgan (Paris, FR)

Access
Abstract
Thumbnail

Access the full session

Poster Session 1 - Device treatment of ventricular arrhythmias and sudden cardiac death

Speakers: Mrs A. Marx, Doctor N. Chan, Doctor T. Brouwer, Doctor M. Kawasaki, Doctor C. Abrahim...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources